Michael Houghton is shown in a University of Alberta handout photo. British scientist Houghton, who works at the University of Alberta, and Americans Harvey J. Alter and Charles M. Rice were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the hepatitis C virus. THE CANADIAN PRESS/HO-University of Alberta MANDATORY CREDIT

U of A researcher shares Nobel prize for hepatitis C virus discovery

WHO estimates there are over 70 million cases of hepatitis C worldwide and 400,000 deaths from it each year

British scientist Michael Houghton, who works at the University of Alberta, and Americans Harvey J. Alter and Charles M. Rice were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the hepatitis C virus.

Announcing the prize in Stockholm, the Nobel Committee noted that the men’s work identified a major source of blood-borne hepatitis that couldn’t be explained by the previously discovered hepatitis A and B viruses. Their work, dating back to the 1970s and 1980s, has helped saved millions of lives, it said.

“Thanks to their discovery, highly sensitive blood tests for the virus are now available and these have essentially eliminated post-transfusion hepatitis in many parts of the world, greatly improving global health,” the committee said.

“Their discovery also allowed the rapid development of antiviral drugs directed at hepatitis C,” it added. “For the first time in history, the disease can now be cured, raising hopes of eradicating hepatitis C virus from the world population.”

Houghton is director of the University of Alberta’s Li Ka Shing Applied Virology Institute.

“Michael Houghton’s achievement cannot be overstated,” said University of Alberta president Bill Flanagan. “Dr. Houghton has made this world a better place. As president of the University of Alberta, the institution where he has dedicated his time, I am proud and exhilarated that his work has been recognized in this way.”

The hepatitis C virus is a major source of liver disease that affects millions worldwide.

WHO estimates there are over 70 million cases of hepatitis C worldwide and 400,000 deaths from it each year. The disease is chronic and a major cause of liver cancer and cirrhosis requiring liver transplants.

John McLauchlan, a professor of viral hepatitis at the University of Glasgow, called the three laureates “pioneers” and said their discovery made the global elimination of the disease possible. In 2016, the World Health Organization issued a strategy to wipe out the disease by 2030.

“That would mark the first time we might possibly control a viral infection using only drugs,” McLauchlan said.

“The only issue is getting drugs to people and places where they desperately need them,” he said, adding that the disease primarily strikes stigmatized populations like drug users and the poor.

Alter, who was born in 1935 in New York, carried out his prize-winning studies at the U.S. National Institutes of Health in Bethesda, where he remains active, the committee said. Rice, born in 1952 in Sacramento, California, worked on hepatitis at Washington University in St. Louis and now works at Rockefeller University in New York. Houghton, born in Britain in 1950, studied at the Chiron Corporation in California before moving to the University of Alberta in Edmonton.

The medicine prize carried particular significance this year due to the coronavirus pandemic, which has highlighted the importance that medical research has for societies and economies around the world.

Will Irving, a virologist at the University of Nottingham, said that identifying hepatitis C had been the “holy grail” in medicine.

“After hepatitis A and B were discovered in the 1970s, it was clear there was still at least one other virus or more that were causing liver damage,” he said.

“We knew there was a virus in the blood supply, because when people had blood transfusions they would get liver damage,” Irving said. “It was recognized as a risk but there was nothing we could do. We didn’t know what the virus was and we couldn’t test for it.”

Nobel Committee member Patrik Ernfors drew a parallel between this year’s prize and the current rush by millions of scientists around the world to combat the coronavirus pandemic.

“The first thing you need to do is to identify the causing virus,” he told reporters. “And once that has been done, that is, in itself, the starting point for development of drugs to treat the disease and also to develop vaccines against the disorder.”

Unlike hepatitis A, which is transmitted via food or water and causes an acute infection that can last a few weeks, hepatitis B and C are transmitted through blood.

American scientist Baruch Blumberg discovered the hepatitis B virus in 1967 and received the 1976 Nobel Prize in medicine, but this did not explain all cases of chronic hepatitis, a disease that was becoming more common even in apparently healthy people who had received or given blood.

“Before the discovery of the hepatitis C virus, it was a bit like Russian roulette to get a blood transfusion,” said Nobel Committee member Nils-Goran Larsson.

Alter was working at the U.S. National Institutes of Health when he discovered that plasma from patients who didn’t have hepatitis B could also could transfer the disease.

“The breakthrough came in 1989, when Michael Houghton and colleagues working at Chiron Corporation used a combination of molecular biology and immunology-based techniques to clone the virus,” said Nobel Committee member Gunilla Karlsson-Hedestam.

Later, Rice confirmed that a cloned hepatitis virus alone could cause persistent infection in chimpanzees and reproduce the disease observed in humans.

The hepatitis C virus belongs to a group known as flaviviruses that also includes West Nile virus, dengue virus and yellow fever virus.

Thomas Perlmann, the Secretary-General of the Nobel Committee, managed Monday to reach two of the winners, Alter and Rice.

“I had to call a couple of times before they answered,” he said. “They seemed very surprised and very, very happy.”

Graham Foster, professor of hepatology at Queen Mary University, said the discovery of hepatitis C had prevented millions from getting sick or dying of the disease or other liver problems and that the awarding of the Nobel to Alter, Houghton and Rice was very well deserved.

Foster said the discovery has had significant impacts in both developing countries, like Egypt and Pakistan, where millions were infected via contaminated medical equipment or procedures, and in developed countries like the U.S., where the blood supply itself was often contaminated.

“This discovery allowed for safe blood transfusion and it allowed the rapid development of treatments for hepatitis C,” Foster said. “We are now in a position where we have drugs that are 96% effective if you take a pill for eight weeks.”

The Nobel Committee often recognizes basic science that has laid the foundations for practical applications in common use today.

“It takes time before it’s fully apparent how beneficial a discovery is,” said Perlmann. “Of course these serological tests have been around for quite a while, but the antiviral drugs that emerged as a consequence of this significant discovery have been much more recent.”

The prestigious Nobel award comes with a gold medal and prize money of 10 million Swedish kronor (over US$1,118,000), courtesy of a bequest left 124 years ago by the prize’s creator, Swedish inventor Alfred Nobel.

Monday’s medicine award is the first of six prizes this year being announced through Oct. 12. The other prizes are for outstanding work in the fields of physics, chemistry, literature, peace and economics.

David Keyton And Frank Jordans, The Associated Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta’s chief medical officer of health, Dr. Deena Hinshaw, confirmed more than 1,000 cases over the weekend Monday afternoon. File photo
COVID-19: Central zone active cases up Monday

‘We’ve now crossed the tipping point,’ says Hinshaw

Right, Ambassador of Hungary to Canada, Her Excellency Dr. Maria Vass-Salazar, lays a wreath at St. Michael’s RC Cemetery in Manfred, Ponoka County on Oct. 25. (Emily Jaycox/Bashaw Star)
Wreath laying ceremony held in Manfred

Ceremony marks 64th anniversary of Hungarian revolution, honours settlers

Alberta has 3,651 active cases of COVID-19. (File photo)
432 new COVID cases sets another record Friday

Central zone holds steady at 126 active cases

B.C. Liberal leader Andrew Wilkinson, B.C. NDP leader John Horgan and B.C. Greens leader Sonia Furstenau. (Black Press Media)
VIDEO: One day until B.C. voters go to the polls in snap election defined by pandemic

NDP Leader John Horgan’s decision to call an election comes more than a year ahead of schedule and during a pandemic

Royal Alexandra Hospital front-line workers walk a picket line after walking off the job in a wildcat strike in Edmonton, on Monday, October 26, 2020. Hospital and health-care workers who staged a one-day illegal walkout returned to work Tuesday while politicians swapped recriminations and accusations in the house over the dispute. THE CANADIAN PRESS/Jason Franson
Alberta health staff return to work, surgeries resume after one-day walkout

AHS estimated 157 non-emergency surgeries, most of them in Edmonton, had to be postponed as a result of the walkout

Prime Minister Justin Trudeau makes his way to provide an update on the COVID pandemic in Ottawa on Tuesday, Oct. 27, 2020. Canada has reached a grim milestone in the COVID-19 pandemic, surpassing 10,000 novel coronavirus deaths. THE CANADIAN PRESS/Sean Kilpatrick
Alberta COVID deaths pushes Canada past milestone of 10,000 deaths

Canada crossed the threshold of 5,000 deaths on May 12, a little over two months after the first was reported

Cases in Ponoka (East Ponoka County) as of Oct. 27. (alberta.ca)
Diagnosed cases of COVID-19 at three Ponoka businesses

Town ‘strongly encouraging’ residents to wear non-medical masks in public

Prime Minister Justin Trudeau provides an update on the COVID pandemic during a press conference in Ottawa on Tuesday, Oct. 27, 2020. THE CANADIAN PRESS/Sean Kilpatrick
Trudeau says pandemic ‘really sucks,’ and that Christmas gatherings are up in the air

The prime minister encouraged residents to continue to follow the advice of local health authorities

The Williams Lake Indian Band is stipulating no-go zones for mushroom picking in areas burned by last summer’s wildfires. 100 Mile Free Press photo
Who controls mushroom harvesting on Indigenous lands?

‘We don’t necessarily know where the mushrooms grow, how old the stands need to be, those types of things.’

Canadian and American flags fly near the Ambassador Bridge at the Canada/USA border crossing in Windsor, Ont. on Saturday, March 21, 2020. THE CANADIAN PRESS/Rob Gurdebeke
U.S. election results one factor that could impact immigration to Canada next year

The survey polled 1,523 Canadians between Oct. 23 and Oct. 25

Alberta’s provincial flag flies on a flag pole in Ottawa, Monday July 6, 2020. The Alberta government is hoping to get more Albertans employed by moving to limit the number and type of temporary foreign workers it allows into the province. THE CANADIAN PRESS/Adrian Wyld
Alberta to limit temporary foreign worker program to save jobs for Albertans

Temporary foreign workers already in the province won’t be affected

Submitted
Montana First Nations councillor gives back to youth

Has pledged 10 per cent of his salary for youth programming

Most Read